Regulation And Legal
Glenmark's RYALTRIS FDA Approval for Pediatric Use
Glenmark received U.S. FDA approval to expand RYALTRIS® nasal spray use to children aged 6-12 years for seasonal allergic rhinitis treatment.
The approval was supported by a Phase 3 study involving 44
